Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Preventions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04199663
What this trial is testing

Socioeconomic Status, Secondary Prevention Activities and Recurrence After a Myocardial Infarction

Who this might be right for
Socioeconomic StatusSecondary PreventionMyocardial Infarction+2 more
Karolinska Institutet 30,191
Not applicableNot Yet RecruitingNCT06904664
What this trial is testing

An Application That Can Provide Early Warning of Temperature Health Risks and Give Protective Suggestions or Personalized Suggestions Based on Patients' Own Secondary Prevention Risk Factors Was Applied to Intervene, and the Intervention Effect of APP on Stroke Recurrence Risk Was Analyzed

Who this might be right for
Acute Ischemic Stroke
Xuanwu Hospital, Beijing 10,184
Not applicableLooking for participantsNCT07233863
What this trial is testing

Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

Who this might be right for
Lymphedema Arm
Dharmais National Cancer Center Hospital 136
Post-approval studies (Phase 4)Study completedNCT01174693
What this trial is testing

Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping

Who this might be right for
Cerebral Infarction
Gangnam Severance Hospital 795
Not applicableStudy completedNCT03648957
What this trial is testing

Lifestyle Counselling as Secondary Prevention in Patients With Minor Stroke and Transient Ischemic Attack

Who this might be right for
Stroke, IschemicStroke HemorrhagicTransient Ischemic Attack
Nordsjaellands Hospital 40
Not applicableStudy completedNCT01207700
What this trial is testing

Secondary Prevention of coRonary Events After Discharge From Hospital (SPREAD)

Who this might be right for
Acute Coronary Syndrome
St. John's Research Institute 806
Not applicableLooking for participantsNCT07550036
What this trial is testing

WomenFocused Education in CArdiac REhabilitation (WECARE) Pilot RCT

Who this might be right for
Cardiovascular DiseasesHeart DiseasesHealth Knowledge, Attitudes, Practice+1 more
University Health Network, Toronto 50
Testing effectiveness (Phase 2)Study completedNCT01449110
What this trial is testing

Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease

Who this might be right for
Cardiovascular Diseases
National Research Council, Spain 150
Not applicableStudy completedNCT01018849
What this trial is testing

Role of Vitamin D in Secondary Prevention of Cardiovascular Events

Who this might be right for
Cardiovascular Disease
Creighton University 24
Not applicableUnknownNCT03044015
What this trial is testing

Primary Care Based Intervention for the Secondary Prevention of Osteoporotic Fractures

Who this might be right for
Osteoporotic Fractures
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 1,800
Not applicableStudy completedNCT03174535
What this trial is testing

Risk Assessment Model for Ischemic Stroke Endpoint Events

Who this might be right for
Ischemic Stroke
China Academy of Chinese Medical Sciences 3,000
Not applicableStudy completedNCT02619422
What this trial is testing

More Intensive Cardiac Rehabilitation Programs in Less Time

Who this might be right for
Acute Coronary Syndrome
Almudena Castro Conde 509
Post-approval studies (Phase 4)Study completedNCT02295475
What this trial is testing

Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeThrombosis
Scott C. Woller, MD 48
Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Not applicableStudy completedNCT04218500
What this trial is testing

The Effectiveness and Safety of Niacinamide 4% and Virgin Coconut Oil 30% for Secondary Prevention of Occupational Hand Dermatitis

Who this might be right for
Contact Dermatitis of Hands
Universitas Indonesia 92
Not applicableStudy completedNCT04693988
What this trial is testing

Early Case Management on Recovery From a Cardiac Event in Women

Who this might be right for
Cardiac Rehabilitation
University of Vermont Medical Center 114
Large-scale testing (Phase 3)Study completedNCT00960869
What this trial is testing

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

Who this might be right for
Gastric Ulcer
POZEN 519
Testing effectiveness (Phase 2)Study completedNCT03428711
What this trial is testing

Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis

Who this might be right for
Superficial Venous Thrombosis of Leg, Secondary Prevention
Quovadis Associazione 560
Not applicableUnknownNCT04908241
What this trial is testing

Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT)

Who this might be right for
StrokeStroke, IschemicStroke Hemorrhagic+10 more
University of British Columbia 96
Not applicableUnknownNCT01826929
What this trial is testing

Effectiveness New Health Care Organization Model in Primary Care for Chronic Cardiovascular Disease Patients Based

Who this might be right for
Ischemic Heart Disease
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana 300
Next Page